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Abstract
Background Human milk vitamin B12 (B12) concentrations depend on maternal status and intake; only few data are
available in high-income countries.
Objective We assessed human milk B12 concentrations during the first 6 months postpartum in Norwegian women and its
association with maternal dietary B12 intake and maternal urinary methylmalonic acid (MMA) concentration.
Methods In this cross-sectional study, 175 mothers, exclusively (80%) or partially (20%) breastfeeding, were included. Milk
B12 was measured by IMMULITE®/IMMULITE® 1000 B12 competitive protein binding assay and urinary MMA relative to
creatinine (MMA/Cr) by liquid chromatography–tandem-mass spectrometry. Maternal habitual B12 intake and supplement
use were estimated using a food frequency questionnaire.
Results Mean human milk B12 concentration was 327 pmol/L (range 140–1089), with 402 pmol/L at 1 month (n= 21),
333 pmol/L at four months (n= 32), and 299 pmol/L at 6 months (n= 21). Maternal B12 intake was 5 µg/d, 89% met the
Estimated Average Requirement, and supplement use did not affect milk B12 concentrations. MMA/Cr was low in all
women compared with published data. In exclusively breastfeeding women, MMA/Cr (beta (95% CI) −42.5 (−82.5, −2.5)
and time since birth (−4.9 (−9.6, −0.3)) were significant predictors of human milk B12 concentrations. There was no
association between total B12 intake and milk B12 concentration or between total B12 intake and MMA/Cr.
Conclusions Maternal B12 status and human milk B12 concentrations are likely sufficient, based on adequate maternal B12
dietary intake combined with low urinary MMA concentrations. Nevertheless, milk B12 concentration fell during 6 months
postpartum while maternal B12 status did not change.
Introduction
Vitamin B12 (B12) is an essential micronutrient for normal
growth and cognitive development in infants [1, 2]. Infant
B12 status depends on both sufficient transfer in utero and
sufficient transfer through breast milk, both of which are
strongly affected by maternal status [2–4]. Maternal
B12 status is a strong predictor of exclusively breastfed
infant B12 status, both at birth and at 6 months postpartum
[5]. In high-income countries, B12 deficiency is rare and
usually observed only in exclusively breastfed infants of
vegetarian mothers [2]. Milk from well-nourished women is
lower in B12 (300 (range 150–700 pmol/L)) compared with
infant formulas (800–1200 pmol/L) [2], and breastfed
infants have lower B12 status than formula fed infants [2].
Several studies have examined B12 status in newborns and
during infancy in populations that are considered B12-
replete. Most of these studies show that infants have lower
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serum B12 and higher methylmalonic acid (MMA) com-
pared with older children and adults, but did not measure
milk B12 [6]. MMA, measured in blood or urine, is an
indicator of B12 status [7]. B12 status of Norwegian women
is assumed to be adequate because of regular consumption
of meat, fish, and dairy products [8]. In a previous study in
Norway, exclusively breastfed infants had lower B12 status
at 4–6 months of age than infants consuming formula or
bovine milk, but human milk B12 concentration was not
measured. The authors suggested that this could be related
to different reference ranges for B12 status in breastfed
infants rather than a sign of B12 deficiency [9]. The current
knowledge on vitamin B12 content in human milk in well-
nourished populations is scarce. Therefore, the aim of the
current study was to assess B12 concentration in human
milk samples and estimate B12 intake in Norwegian
mothers and infants during the first 6 months of lactation.
The infants’ age ranged from 0 to 24 weeks, 80% were
exclusively breastfed. A secondary aim was to examine
predictors of human milk B12 concentration, including
maternal urinary MMA and maternal dietary intake of B12
from food and supplements.
Methods
Population and study design
In this cross-sectional study in Norway, lactating women
were recruited during a postnatal care visit from October to
December 2016, as part of a study on iodine status in lac-
tating women [10]. Five out of 18 Mother and Child Health
Centers in Oslo were randomly selected from a list stratified
into five areas representing different regions and socio-
economic groups in Oslo. Women who had delivered an
infant within the last 6 months and who were fully or par-
tially lactating and who could read and write Norwegian
were invited into the study. In total, 254 women fulfilled the
inclusion criteria, 193 accepted and 175 (69%) completed
the study. Participation was equally distributed among the
Mother and Child Health Centers (65–75%). The partici-
pants responded to a questionnaire on background infor-
mation, habitual intake of 31 food groups in the last four
weeks, and intake of all dietary supplements (described
below). Self-reported background information included the
women’s age, time since birth, previous pregnancies, height
and weight at the time of milk sampling, educational level,
and smoking habit. Participants were also asked about their
country of birth, how long they had lived in Norway, and
what language they spoke at home. The women who agreed
to participate gave written informed consent. The present
study was conducted according to the guidelines in the
Declaration of Helsinki and was approved by the Regional
Committee for Medical and Health Research Ethics Norway
(2015/1845).
Collection of human milk samples
Four breast milk samples per woman were obtained by
manual expression into labeled 50 mL polypropylene cen-
trifuge tubes (Sarstedt, Nümbrecht, Germany); two in the
morning just after eating breakfast, and two in the after-
noon; two with foremilk; and two with hind milk (one with
foremilk and one with hind milk on each occasion). Each
woman received detailed oral and written information on
how and when to collect and how to store the human milk
samples. Between sampling, the milk samples were stored
refrigerated at 2–4 °C from the time of collection until
transportation to the laboratory. The four milk samples were
pooled (equal volume from each sample) and stored at
−80 °C until analysis.
Collection of urine samples
A spot nonfasting maternal urine sample was obtained in
the morning, shortly after breastfeeding the infant. The
sampled urine was collected into a labeled 100 mL Vacu-
ette® Urine beaker (Greiner Bio-One, Kremsmünster, Aus-
tria). The urine sample was stored refrigerated from the time
of sampling until transportation to the laboratory. In the
laboratory, a subsample of urine was withdrawn from the
beaker into a 9.5 mL Vacuette® Urine tube (Greiner Bio-
One, Kremsmünster, Austria), which was stored at −80 °C
until analysis.
Biochemical analyses
B12 in human milk was analyzed at the USDA, ARS
Western Human Nutrition Research Center, Davis, USA, by
the IMMULITE®/IMMULITE® 1000 Vitamin B12 solid-
phase; competitive chemiluminescent enzyme immu-
noassay (Siemens, Duluth, GA, USA) [11]. Urinary MMA
and creatinine concentration were measured by liquid
chromatography–tandem mass spectrometry (LC-MS/MS)
at the Department of Nutrition, Institute of Basic Medical
Sciences, University of Oslo, Norway. LC-MS/MS was
performed using a Shimadzu LC-20ADXR Prominence LC
system (Kyoto, Japan) coupled to a Sciex QTRAP5500
mass spectrometer with Turbo V ion source and Tur-
boIonspray probe (Framingham, MA, USA). Separation of
the analytes was achieved using a Restek Ultra AQ C18
(100 × 4.6 mm, 3 μm) column. The mobile phases were (A)
with an aqueous solution of formic acid [0.4%] and (B)
methanol with 0.4% formic acid at a flow rate of 0.8 mL/
min. The separation was achieved with a linear gradient
from 80% (A) for 1 min and 20% (A) from 1 to 3 min
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followed by a linear gradient back to 80% (A) over 5 min.
The whole run was 5 min and the injection volume was
15 µL. Linear calibration curves of the peak area ratios of
analytes and internal standards were used for quantification.
Coefficient of variation for MMA was 1.7%. One person
with an MMA concentration four times higher than the rest
of the group was excluded from the analysis.
Dietary intake of B12 from food and supplements
The habitual food assessment comprised 31 questions about
average consumption frequency of major food groups dur-
ing the last four weeks. The questions about each food item
had seven alternative responses; rarely/never, less than
weekly, 1–3 times weekly, 4–6 times weekly, 1–2 times
daily, 3–4 times daily, and 5 times daily or more. We
transformed frequencies into daily amounts using standard
portion sizes for women. Daily intakes of energy and
nutrients, including B12 content were estimated using the
Norwegian Food Composition Table [12] and FoodCalc
[13]. Participants were also asked to report the names and
habitual frequency (times per week) of all supplements
used. They were also asked to report the supplements
consumed during the last 24 h. The amount of B12 con-
tributed by supplements (habitual and in the last 24 h) was
estimated using information listed by the producers. All
reported supplements included other vitamins and micro-
nutrients in addition to B12. A typical vitamin supplement
in Norway contains no more than 10 µg of B12 (median
2.5 µg, range 1.3–9.0 µg). Notably, two participants that
used prescription tablets (TrioBe tablets; Meda AS (Mylan
Health Care Norway), Asker, Norway), of a high dose
supplement containing B12 (500 µg), folic acid and vitamin
B6 [14], were excluded from the dataset.
Variable definitions and cutoff values
The Institute of Medicine defines the Adequate Intake (AI)
of B12 for infants 0–6 months to be 0.4 μg/d [15]. The
concentration of human milk B12 necessary for exclusively
breastfed infants to attain the daily AI (0.4 μg/d) is esti-
mated to be 310 pmol/L assuming an average milk volume
of 780 mL/d [2, 3]. The milk B12 concentration in well-
nourished women is in the range 150–700 pmol/L, with
mean 300 pmol/L [2]. The estimated B12 intake of
0–6 months old fully or partially breastfed infants was
calculated using historic data on age-in-months human milk
consumption per day in infants [16]. The Recommended
Daily Allowance (RDA) for B12 for lactating women is
2.8 μg/d and the EAR is 2.4 μg/d [15]. In the Nordic
countries, the RDA for lactating women is 2.6 µg/d [17].
Normal range for MMA/Cr in urine is 0.0–3.6 mmol/mol
creatinine [18, 19]. The Human Development Index (HDI)
is a statistical composite index of life expectancy, educa-
tion, and per capita income indicators, which is used to rank
countries into four tiers of human development [20].
Statistics
All data processing and analyses were done using IBM
SPSS statistics version 24 (IBM Corp., Armonk, NY,
USA). Spearman correlations were performed to determine
associations between variables. Vitamin B12 concentration
in milk was skewed so all analyses were done using log
transform data. In the results, we showed not transformed
data to make the interpretation easier. Multiple linear
regression analyses were used to explore predictors of B12
concentration in human milk as the outcome variable. The
exposure variables were maternal age (years), time since
birth (weeks), maternal BMI, smoking status, parity, HDI
index, vegetarian practice, maternal dietary B12 intake,
B12 supplements (μg/d), urine creatinine, and maternal
urinary MMA/Cr (expressed as mmol/mol creatinine). All
covariates that showed associations (p < 0.10) in the crude
regression analysis were included in the preliminary mul-
tiple regression models. Excluded variables were reintro-
duced and those that were still associated in this model (p <
0.10) were retained in the final model [21]. The graphs
depicting the association (95% CI) between B12 in milk and
time since birth, B12 in milk and maternal B12 intake, B12
in milk and maternal urinary MMA/Cr, and maternal urin-
ary MMA/Cr and maternal B12 intake, were generated in
GraphPad Prism (version 8.1.1, GraphPad Software, San
Diego, CA, USA).
Results
The mean age of the mothers was 32 years, 65% were born
in Norway (>80% in high HDI countries), and 51% had
more than 4 years of higher education (Table 1). The mean
time since birth at recruitment of the mothers was 11 weeks.
Eighty percent of the women were exclusively breastfeed-
ing their infant when the study was conducted. Thirty-four
percent reported habitual use of dietary supplements con-
taining B12, while 23% had taken this supplement in the
last 24 h. Only 2% of the women were vegetarians.
Mean dietary intakes of B12 from food and from food
and dietary supplements combined were 4.1 and 5.0 µg/d,
respectively (Table 2). Mean daily energy intake was
1621 kcal/6802 kJ. The calculated total B12 intake was
significantly higher in supplement users (6.4 μg/d) than in
nonsupplements users (4.3 μg/d). Eighty-two percent of the
mothers met the RDA of 2.8 μg/d, 85% met the Nordic
RDA of 2.6 µg/d, and 89% met the EAR of 2.4 μg/d.
The main dietary sources of B12 for the mothers were
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milk, yogurt, and cheese, contributing on average 35% of
the B12 intake, followed by fish (27%), multivitamin sup-
plements (18%), eggs (14%), and meat (6%). Maternal
urinary MMA was 11.3 µmol/L and creatinine concentra-
tion was 9.9 mmol/L. No women had elevated urinary
MMA/Cr, defined as MMA/Cr above 3.6 mmol/mol.
The mean milk B12 concentration was 327 pmol/L
(range 140–1089 pmol/L) (Table 3), with no significant
differences between supplement users and nonsupplement
users (mean (SD) 340 (179) pmol/L vs. 320 (169) pmol/L,
p= 0.46). According to time since birth, mean milk con-
centration was 402 pmol/L at 1 month, 333 pmol/L at
4 months and 299 pmol/L at 6 months. Sixty-two percent of
the women had a milk B12 concentration >310 pmol/L, and
nine women had >700 pmol/L. Only one woman had a milk
B12 concentration <150 pmol/L.
In women who were exclusively breastfeeding, there
was a negative association between B12 concentration in
milk and time since birth (beta (95% CI) −5.0 (−9.7,
−0.2), p= 0.04) (Fig. 1). We found no association
between total maternal B12 intake and B12 concentration
in breast milk (beta (95% CI) 3.8 (−7.0, 14.6), p= 0.49)
or between total maternal B12 intake and urinary MMA/Cr
(beta (95% CI) −0.61 (−1.4, 0.21), p= 0.14). There was
an inverse association between MMA/Cr in urine and B12
concentration in milk (beta (95% CI) −41.4 (−79.8,
−2.9), p= 0.03. There was no association between urinary
MMA/Cr and time since birth, beta (95% CI) −0.0
(−0.01, 0.23), p= 0.24).
The mean estimated B12 intake from human milk from
nonsupplemented mothers, in exclusively breastfed infants
was 0.31 μg/d, (5, 95 percentiles: 0.16, 0.67) (Table 4). In
exclusively breastfeeding women, a multiple linear regres-
sion analysis of predictors of human milk B12 concentra-
tion showed that maternal urinary MMA/Cr (beta (95% CI)
−42.5 (−82.5, −2.5), p= 0.03) and time since birth in
weeks (beta (95% CI) −4.9 (−9.6, −0.3), p= 0.04) were
significant predictors.
Discussion
Our data adds to the knowledge on breast milk B12 con-
centrations from well-nourished women during the first
6 months of lactation in high-income countries. The women
had adequate B12 intakes and low urinary MMA/Cr, indi-
cative of an adequate B12 status. Breast milk B12 con-
centrations were within the normal range for well-nourished
women and no differences were found between supplement
users and nonsupplement users, indicating that supplement
use did not affect the milk B12 concentration.
The mean (SD) concentration of B12 in human milk in
our study is similar to estimates for 6 weeks postpartum in a
previous study in Norway [22] and at 4 months among
Danish women [23] (Table 5). However, the milk B12
concentrations were lower in our study than among women
from Canada [24] and USA [25], all of whom consumed a
supplement containing high amounts of B12 during both
pregnancy and lactation, compared with the 35% consum-
ing supplements with moderate amounts of B12 during
lactation in our sample.
Table 1 Sample characteristics maternal characteristics in lactating
women (n= 172).
Characteristics Mean ± SD
Age mother, years 32 ± 4.2
Time since birth, weeks 11 ± 6.6
BMI, kg/m2 a 25 ± 4.7





One child 104 (60.5)
More than one child 68 (39.5)
Lactation
Exclusive breastfeeding 138 (80.2)
Partial breastfeeding 34 (19.8)
Education
≤12 years (high school) 32 (18.6)
1–4 years higher education 51 (29.6)





Very high HDI 131 (76.2)
High HDI 13 (7.6)
Medium HDI 11 (6.4)
Low HDI 17 (9.9)
Habitual use of B12 containing supplement
No 113 (65.7)
Yes 59 (34.3)







bHDI (human development index) is a statistic composite index of life
expectancy, education, and per capita income indicators. It is used to
rank countries into four tiers of human development from low to high.
cAll four were lacto-ovo vegetarians.
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In Norway, foods are not fortified with B12, and B12 intake
depends on the amounts of foods consumed with a naturally
content of B12 in a bioavailable form. Traditionally, Norwe-
gians have a high consumption of animal source foods [8],
which agrees with the finding in our study. Compared with our
data, B12 intakes were higher among women participating in
the Norwegian Mother and Child Cohort Study (MoBa)
(8.5 µg/d from diet and supplements and 6.5 µg/d from diet
only) [8], possibly because our FFQ only covered 31 foods
compared with 250 foods in MoBa. Our FFQ was designed to
capture the intakes of major food groups and showed good
validity for calculated iodine intake [26]. Nevertheless, we
may have missed some B12 food sources and therefore
underestimated total B12 intake within food groups, which
could explain the lack of association between B12 intake and
milk concentration. In studies from low-income countries with
a higher prevalence of deficient or marginal B12 status,
maternal vitamin B12 intake was associated with human milk
B12 concentrations at 1, 6, and 12 months postpartum in
Kenya [27] and Guatemala [1, 2, 28].
Notably, no differences were found in milk B12 con-
centration between supplement users and nonsupplement
users. Maternal B12 supplementation in lactation may be
too late to restore adequate milk concentrations and infant
status [3]. Randomized controlled trials show that providing
recommended amounts of B12 in supplements increased
adult and infant serum B12, and human milk concentrations
of the vitamin, although not by a substantial amount [2].
Our findings indicate that supplement use did not decrease
MMA/Cr concentrations, which could be expected if the
women had insufficient B12 status.
We found increasing breast milk B12 concentration with
decreasing maternal urinary MMA/Cr, indicating the
expected relationship between maternal B12 status and B12
in human milk in these well-nourished women with normal
B12 status. No woman had MMA/Cr above the cutoff,
indicating that her B12 status was sufficient. In addition, our
data show that even in the range of normal values, maternal
B12 status—based on urinary MMA/Cr—is associated with
milk B12 concentrations.
B12 deficiency does not occur in healthy infants fed milk
from mothers with adequate B12 status [15]. The B12
concentration in milk of Brazilian mothers, which was used
to set the AI, was 0.3 µg/d and rounded up to 0.4 µg/d [15],
which is in agreement with our findings in milk provided to
EBF-infants by unsupplemented mothers. There is no
agreed-upon cutoff for adequate B12 concentration in
human milk; however, Allen et al. have suggested a mean
B12 concentration of 300 (range 150–700) pmol/L in well-
nourished women [2]. Only one woman in our study had a
Table 2 Mean (SD) and
percentile distribution of B12
dietary intake and MMA urinary
concentrations in lactating
women in Norway (n= 172).
n (%) above Percentiles
Mean SD Cutoff 5 25 Median 75 95
B12 intake food only, μg/d 4.1 1.9 – 1.5 2.7 3.8 5.1 7.6
B12 intake supplements, μg/da 2.7 1.5 1.3 2.0 2.5 2.6 9.0
B12 total intake, μg/db,c 5.0 2.4 155 (89) 1.6 3.4 4.9 6.2 9.3
Urine MMA, µmol/L 11.3 9.3 – 0.9 5.4 10.2 15.5 26.0
Urine MMA/Cr, mmol/mold 1.1 0.5 0 (0) 0.3 0.7 1.0 1.3 2.1
aB12 intake by supplement users only, n= 59.
bEstimated Average Requirement (EAR) for lactating women 2.4 μg/d.
cMean energy intake was 1621 kcal/6802 KJ.
dNormal range for MMA in urine is 0.0–3.6 mmol/mol creatinine (Cr) [18], and 3.6 is used as the cutoff.
Table 3 Mean (SD) vitamin B12
concentration in human milk
from supplement users and
nonsupplement users by time
since birth in months (n= 170).

















1 (n= 21) 370 (208) 1.25 (0.63) 422 (251) 0.92 (0.28) 402 (231) 1.05 (0.46)
2 (n= 57) 308 (161) 0.95 (0.64) 337 (178) 0.98 (0.44) 327 (172) 0.97 (0.51)
3 (n= 25) 257 (76) 1.21 (0.52) 272 (114) 1.21 (0.58) 266 (99) 1.21 (0.54)
4 (n= 32) 390 (211) 0.95 (0.30) 275 (89) 1.34 (0.58) 333 (170) 1.16 (0.50)
5 (n= 14) 491 (313) 0.62 (0.22) 338 (226) 1.05 (0.55) 360 (232) 0.99 (0.54)
6 (n= 21) 367 (122) 0.98 (0.41) 279 (107) 1.04 (0.43) 299 (78) 1.10 (0.41)
Total 340 (179) 1.03 (0.52) 320 (169) 1.07 (0.49) 327 (172) 1.11 (0.49)
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milk B12 concentration below 150 pmol/L, thus, we assume
that the Norwegian breastfed children met their vitamin B12
requirement from human milk.
The strengths of this study are the relatively high number
of lactating women, of whom 80% were exclusively
breastfeeding, who provided milk samples and gave
detailed information of dietary intake and supplement use.
The inclusion of lactating women with infants from 0 to
24 weeks is a strength, given that B12 levels fluctuate
throughout lactation. We also used the new and more
accurate method for measurement of B12 in human milk
[11]. The main limitations of the study include the lack of
Fig. 1 The graphs show associations among human milk B12,
maternal B12 intake and urinary MMA, and infant age. a Asso-
ciation between B12 concentration in human milk and time since birth
in weeks. b Association between B12 concentration in human milk
and total maternal B12 intake. c Association between B12
concentration in human milk and maternal urinary MMA/Cr.
d Association between maternal urinary MMA/Cr and total maternal
B12 intake. In 138 exclusively breastfed Norwegian infants. The
dotted lines indicate 95% CI of the association.
Table 4 Estimated vitamin B12 intake by time since birth in
exclusively breastfeda infants of mothers not using vitamin B12














1 (n= 9) 0.699 490 (274) 0.47 (0.26)
2 (n= 33) 0.731 328 (160) 0.33 (0.16)
3 (n= 13) 0.751 249 (75) 0.25 (0.08)
4 (n= 14) 0.780 260 (85) 0.28 (0.09)
5 (n= 11) 0.796 283 (129) 0.31 (0.14)
6 (n= 9) 0.854 205 (44) 0.29 (0.06)
Total 0.780 308 (159) 0.31 (0.15)
aEighty percent (n= 140) of the infants were exclusively breastfeed
and 66% (n= 92) of the mothers used no supplements, two women
were excluded due to intake of high vitamin B12 containing
supplements and one women with high MMA.
bBased on milk intakes of exclusively infants from developed
countries, WHO, 2002 [16].








Our study Norway 172 11 weeksa 34 327a
32 4 months 49 333
Varsi [22] Norway 83 6 weeks 47 313
4 months 291
Greibe [23] Denmark 25 2 weeks 79 760
4 months 67 290
9 months 50 440
Chebaya [24] Canada 109 8 weeks 100b 452
Lildballe [25] USA 24 4–12 weeks 100b 565
aMean time postpartum of sampling and mean concentration of milk
B12 for all time points.
bSupplements used during both pregnancy and lactation.
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data on maternal and infant B12 status in blood and the fact
that we only had one milk sample per woman. Although the
milk sample was a pooled sample including two samples
prior to feeding and two samples after feeding, the samples
were collected within a narrow time frame. The FFQ
included a limited number of food questions and the cal-
culated mean energy intake indicates that the FFQ did not
capture total food intake. In spite of this, the calculated B12
intake was above the RDI for the majority of the partici-
pants. Finally, maternal B12 status depend not only on
recent B12 intake, but on their internal B12 store. Partici-
pants may have taken B12 containing dietary supplements
during pregnancy contributing to higher stores, but we have
no information on supplements use during pregnancy.
Conclusion
Milk B12 concentration and maternal B12 status were
assumed to be adequate in these healthy, well-nourished
women based on adequate dietary B12 intake and low
concentrations of maternal urinary MMA/Cr. The decline of
milk B12 concentrations over the course of lactation appears
to be independent of maternal status in well-nourished
populations. The milk B12 concentrations reported here
augment the sparse data available for estimating infant and
maternal requirements for the vitamin. More research is
needed to gain a better understanding of maternal B12
transfer into milk and effects of milk B12 on infant status.
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